ICHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ichor Holdings Ltd (ICHR) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the stock has received positive analyst upgrades and price target increases, the technical indicators suggest a neutral to slightly bearish trend in the short term. Additionally, the company's financial performance shows mixed results with declining revenue and gross margin, despite improvements in net income and EPS. The options data indicates bearish sentiment with a high put-call volume ratio. Given the lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals, it is better to hold off on investing in ICHR for now.
The technical indicators are mixed. The MACD is negatively expanding, indicating bearish momentum. The RSI is neutral at 38.439, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its key support level of 43.803, with resistance at 48.776. This suggests limited upside potential in the short term.
The company has guided revenue ahead of pre-announcement levels, and there is optimism about its leverage to fast-growing segments.
The company's revenue and gross margin have declined YoY, and the MACD indicates bearish momentum. Options data shows bearish sentiment, and there is no recent news or significant insider/hedge fund activity to act as a catalyst. Additionally, the stock's valuation leaves little margin for error, as noted by analysts.
In Q4 2025, revenue dropped by 4.15% YoY to $223.6M, while gross margin decreased by 3.55% YoY to 10.06%. However, net income improved significantly, increasing by 304.79% YoY to -$15.96M, and EPS improved by 283.33% YoY to -$0.46. The company is showing signs of recovery but still faces challenges in profitability.
Analysts are broadly positive, with multiple upgrades to Buy and price targets raised significantly (e.g., $53, $52, $55). However, one firm downgraded the stock to Perform, citing valuation concerns and limited margin for error. Overall, analysts expect strong growth in 2026 and 2027, with a steady catalyst profile.
